Jun Li

Dr Jun Li graduated with a BSc in biomedical sciences and a PhD in medical sciences from the University of Aberdeen. He then worked as a postdoc in cancer research at the University of Edinburgh. After years in academia, he joined Biocytogen pharmaceuticals as a group leader of study directors, providing preclinical pharmacology consultations for international biopharmaceutical companies. He was then appointed as the Director of in vivo Pharmacology by Biosion, Inc. and led several pipeline developments. At present, he is the Head of preclinical oncology at GemPharmatech.